Skip to main content
Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.89
-0.20 (-3.28%)
At close: Nov 4, 2024, 4:00 PM
5.73
-0.16 (-2.72%)
Pre-market: Nov 5, 2024, 4:15 AM EST

Ardelyx Revenue

Ardelyx had revenue of $98.24M in the quarter ending September 30, 2024, with 74.21% growth. This brings the company's revenue in the last twelve months to $251.85M, up 87.57% year-over-year. In the year 2023, Ardelyx had annual revenue of $124.46M with 138.61% growth.

Revenue (ttm)
$251.85M
Revenue Growth
+87.57%
P/S Ratio
5.47
Revenue / Employee
$943,255
Employees
267
Market Cap
1.40B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Teladoc Health 2.59B
Progyny 1.13B
Evotec SE 844.79M
BioCryst Pharmaceuticals 412.58M
STAAR Surgical Company 341.22M
Arcus Biosciences 247.00M
Schrödinger 200.63M
Revenue Rankings

ARDX News

More News